Deepinder Goyal's Temple Acquires London Longevity Firm Longevous
Deepinder Goyal's wearable technology startup Temple has acquired London-based longevity medicine practice Longevous. The acquisition aims to bolster Temple's clinical and scientific teams ahead of its product launch.
Temple, a startup focused on wearable technology founded by Deepinder Goyal, has acquired London-based Longevous, a practice specializing in longevity medicine. The deal is expected to strengthen Temple's clinical and scientific capabilities as it prepares to launch its first product.
Longevous founders Robert Mohr and Avi Roy, along with their team, will join Temple on a full-time basis. Mohr will assume the role of Chief Medical Officer, overseeing the clinical rigor of the startup's experiments and health claims. Roy will lead the scientific division as Head of Science.
Longevous focuses on preventive and precision medicine, utilizing science-backed therapies and health data to enhance clients' long-term health and lifespan. The practice will continue its operations under Temple's ownership, with its founders continuing to serve existing clients.
Temple's wearable device is nearing its launch, with pre-orders for a limited edition expected soon and shipments anticipated by the end of 2026. The device is being developed based on Goyal's biological research initiative, Continue Research. Temple secured $54 million in seed funding in February.